Ascend Wellness Holdings (AAWH) EPS (Weighted Average and Diluted) (2020 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly EPS (Weighted Average and Diluted) of -$0.15 in Q1 2026, up 37.5% quarter-over-quarter from -$0.24 in Q4 2025, and down 66.67% on a YoY basis from -$0.45 in Q1 2025.
Ascend Wellness Holdings (AAWH) EPS (Weighted Average and Diluted) (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' EPS (Weighted Average and Diluted) history runs 7 years deep, the most recent figure standing at -$0.15 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) fell 66.67% year-over-year to -$0.15; the TTM figure through Mar 2026 stood at -$0.64 (down 60.0% YoY), while the FY2025 annual figure was -$0.58, down 45.0% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.15 for Q1 2026 at Ascend Wellness Holdings, up from -$0.24 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.0 in Q2 2023 to a low of -$0.24 in Q4 2025.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.11 across 5 years, with a median of -$0.1 in 2023.
- The sharpest annual moves came in 2023 and 2024: EPS (Weighted Average and Diluted) jumped 103.98% in 2023, then slumped 2383.8% in 2024.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.08 in 2022, then decreased by 12.5% to -$0.09 in 2023, then rose by 11.11% to -$0.08 in 2024, then plunged by 200.0% to -$0.24 in 2025, then soared by 37.5% to -$0.15 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.15 (Q1 2026), -$0.24 (Q4 2025), and -$0.13 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -0.40 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -0.40 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.80 |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | -0.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.15 |
| Dec 31, 2025 | -0.24 |
| Sep 30, 2025 | -0.13 |
| Jun 30, 2025 | -0.12 |
| Mar 31, 2025 | -0.09 |
| Dec 31, 2024 | -0.08 |
| Sep 30, 2024 | -0.13 |
| Jun 30, 2024 | -0.10 |
| Mar 31, 2024 | -0.09 |
| Dec 31, 2023 | -0.09 |
| Sep 30, 2023 | -0.05 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | -0.10 |
| Dec 31, 2022 | -0.08 |
| Sep 30, 2022 | -0.09 |
| Jun 30, 2022 | -0.11 |
| Mar 31, 2022 | -0.16 |
| Dec 31, 2021 | -0.07 |
| Sep 30, 2021 | -0.08 |
| Jun 30, 2021 | -0.30 |